Picture of Phaxiam Therapeutics SA logo

PHXM — Phaxiam Therapeutics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Erytech Confirms Plans To Submit BLA For Eryaspase In Hypersensitive All Patients

July 21 (Reuters) - Erytech Pharma SA  ERYP.PA :
    * ERYTECH CONFIRMS PLANS TO SUBMIT BLA  FOR ERYASPASE IN
HYPERSENSITIVE ALL PATIENTS
    * ERYTECH PHARMA SA - COMPANY EXPECTS TO SUBMIT BLA BEFORE
END OF
YEAR

Source text for Eikon:  ID:nGNXcbBhYn 
Further company coverage:  ERYP.PA 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Phaxiam Therapeutics SA

See all news